Quick answer
The Cooper Companies, Inc. (COO) reported revenue of $4.09B and net income of $374.9M for the fiscal year ended 2025-10-31, up 5.1% from $3.90B the year before, per its 10-K filed with the SEC on 2025-12-05. Long-term debt stood at $2.46B.
Data as of 2025-10-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-10-31) | $4.09B | $374.9M | $2.46B |
| 2024 (FY ending 2024-10-31) | $3.90B | $392.3M | $2.55B |
| 2023 (FY ending 2023-10-31) | $3.59B | $294.2M | $2.52B |
| 2022 (FY ending 2022-10-31) | $3.31B | $385.8M | $2.35B |
| 2021 (FY ending 2021-10-31) | $2.92B | $2.94B | $1.40B |
| 2020 (FY ending 2020-10-31) | $2.43B | $238.4M | $1.38B |
| 2019 (FY ending 2019-10-31) | $2.65B | $466.7M | $1.26B |
| 2018 (FY ending 2018-10-31) | $2.53B | $139.9M | $1.99B |
| 2017 (FY ending 2017-10-31) | $2.14B | $372.9M | $1.15B |
| 2016 (FY ending 2016-10-31) | $1.97B | $273.9M | $1.11B |
Related
- COIN revenue, net income and debt history (Coinbase Global, Inc.)
- COKE revenue, net income and debt history (Coca-Cola Consolidated, Inc.)
- COLB revenue, net income and debt history (Columbia Banking System, Inc.)
- COP revenue, net income and debt history (ConocoPhillips)
- COR revenue, net income and debt history (Cencora, Inc.)
- CORT revenue, net income and debt history (Corcept Therapeutics Inc)
- COST revenue, net income and debt history (Costco Wholesale Corp /New)
- CPAY revenue, net income and debt history (Corpay, Inc)
Last updated 2026-10-16. Data only, not financial or tax advice.